Esperion Therapeutics | ESPR - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 384.69B 19.14B 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Alterity Therapeutics Limited AUD 36M 20M 2026-06
Amarin USD 290M 51M 2025-12
Amgen USD 189.89B 13.64B 2026-03
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Cipla INR 988.89B 231.9B 2026-03
CSL USD 55.89B 20.42B 2025-12
Cytokinetics USD 8.19B 420M 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Geron USD 955M 112M 2026-03
Halozyme Therapeutics USD 7.66B 257M 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 11.91B 11.05B 2026-06
Pfizer USD 153.81B 12.24B 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
United Therapeutics USD 25.19B 4.21B 2026-03
Vanda Pharmaceuticals USD 279M 6M 2024-12